Stephan Fritschi
Profile
Stephan Paul Fritschi currently works at CARBOGEN AMCIS AG, as Chief Executive Officer from 2025, Carbogen Amcis Ltd., as Chief Executive Officer from 2025, and CARBOGEN AMCIS (Shanghai) Co., Ltd., as Member-Supervisory Board.
Dr. Fritschi also formerly worked at Carbogen Amcis Ltd., as Director and Dishman Carbogen Amcis Ltd., as Executive Vice President-Business units.
Stephan Fritschi active positions
| Companies | Position | Start |
|---|---|---|
CARBOGEN AMCIS (Shanghai) Co., Ltd.
CARBOGEN AMCIS (Shanghai) Co., Ltd. Engages in production and supply of pharmaceutical intermediates and active pharmaceutical ingredients | Director/Board Member | - |
CARBOGEN AMCIS AG
CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology Provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries | Chief Executive Officer | 01/04/2025 |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Develops and commercializes pharmaceutical products | Chief Executive Officer | 31/03/2025 |
Former positions of Stephan Fritschi
| Companies | Position | End |
|---|---|---|
| DISHMAN CARBOGEN AMCIS LIMITED | Corporate Officer/Principal | - |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Develops and commercializes pharmaceutical products | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 4 |
|---|---|
CARBOGEN AMCIS AG
CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology Provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries | Health Technology |
Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. Provides manufacturing and support services for the pharmaceutical industry | |
CARBOGEN AMCIS (Shanghai) Co., Ltd.
CARBOGEN AMCIS (Shanghai) Co., Ltd. Engages in production and supply of pharmaceutical intermediates and active pharmaceutical ingredients | |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Develops and commercializes pharmaceutical products |
- Stock Market
- Insiders
- Stephan Fritschi
















